WEST PHARMACEUTICAL SERVICES, INC. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/72e79d2c-d0e9-48bf-a0b3-bb63115bebe0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $493.7M | 2025-01-01 – 2025-12-31 | evidence 0000105770-26-000010 |
| FY 2024 | $492.7M | 2024-01-01 – 2024-12-31 | evidence 0000105770-25-000013 |
| FY 2023 | $593.4M | 2023-01-01 – 2023-12-31 | evidence 0000105770-24-000015 |
| FY 2022 | $585.9M | 2022-01-01 – 2022-12-31 | evidence 0000105770-23-000012 |
| FY 2021 | $661.8M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-003342 |
| FY 2020 | $346.2M | 2020-01-01 – 2020-12-31 | evidence 0000105770-21-000008 |
| FY 2019 | $241.7M | 2019-01-01 – 2019-12-31 | evidence 0000105770-21-000008 |
| FY 2018 | $206.9M | 2018-01-01 – 2018-12-31 | evidence 0000105770-21-000008 |
| FY 2010 | $65.3M | 2010-01-01 – 2010-12-31 | evidence 0000105770-11-000016 |
| FY 2009 | $72.6M | 2009-01-01 – 2009-12-31 | evidence 0000105770-11-000016 |
| FY 2008 | $86.0M | 2008-01-01 – 2008-12-31 | evidence 0000105770-11-000016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
WEST PHARMACEUTICAL SERVICES, INC. — all facts · Revenue · Operating Income